| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,859 |
7,908 |
$628K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
758 |
607 |
$323K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,931 |
2,156 |
$130K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
861 |
171 |
$122K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
710 |
579 |
$99K |
| 94375 |
|
4,814 |
3,610 |
$82K |
| 99457 |
|
1,672 |
1,308 |
$46K |
| 99215 |
Prolong outpt/office vis |
605 |
356 |
$45K |
| 94060 |
|
1,497 |
1,152 |
$42K |
| 95117 |
|
4,182 |
1,538 |
$34K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
179 |
123 |
$30K |
| 94729 |
|
1,487 |
1,145 |
$27K |
| 95811 |
|
76 |
54 |
$23K |
| 94727 |
|
1,476 |
1,137 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
226 |
158 |
$19K |
| 96160 |
|
6,951 |
5,192 |
$18K |
| 31231 |
|
178 |
126 |
$17K |
| 99454 |
|
623 |
457 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,031 |
719 |
$13K |
| 94664 |
|
1,115 |
862 |
$8K |
| 95706 |
|
77 |
26 |
$7K |
| 99490 |
Ccm add 20min |
885 |
616 |
$5K |
| 95717 |
|
80 |
26 |
$4K |
| 99406 |
|
497 |
375 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
99 |
70 |
$3K |
| 94621 |
|
56 |
41 |
$3K |
| 99453 |
|
249 |
193 |
$3K |
| E0570 |
Nebulizer, with compressor |
18 |
14 |
$2K |
| 99458 |
|
61 |
60 |
$2K |
| 98980 |
|
89 |
70 |
$2K |
| 96127 |
|
652 |
512 |
$2K |
| 94070 |
|
70 |
46 |
$1K |
| 99439 |
|
232 |
183 |
$1K |
| 94770 |
|
45 |
42 |
$1K |
| 95024 |
|
22 |
12 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
54 |
31 |
$1K |
| 94618 |
|
46 |
42 |
$626.33 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
667 |
567 |
$481.18 |
| 36600 |
|
16 |
16 |
$272.88 |
| 82803 |
|
13 |
13 |
$262.57 |
| 98976 |
|
18 |
13 |
$249.73 |
| 82330 |
|
13 |
13 |
$185.35 |
| 83605 |
|
13 |
13 |
$144.87 |
| 99091 |
|
141 |
128 |
$123.96 |
| 82435 |
|
13 |
13 |
$100.76 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
34 |
28 |
$96.20 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
43 |
26 |
$76.33 |
| A7015 |
Aerosol mask, used with dme nebulizer |
50 |
38 |
$74.85 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
47 |
36 |
$45.04 |
| 85014 |
|
13 |
13 |
$32.12 |
| 99451 |
|
21 |
15 |
$5.70 |
| 82565 |
|
15 |
13 |
$2.98 |
| 90785 |
|
84 |
67 |
$1.94 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,065 |
1,554 |
$1.54 |
| 3074F |
|
1,258 |
1,055 |
$0.10 |
| 3078F |
|
1,196 |
982 |
$0.09 |
| 1160F |
|
1,079 |
893 |
$0.09 |
| 1159F |
|
1,080 |
894 |
$0.09 |
| G9434 |
Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given |
146 |
108 |
$0.05 |
| 3077F |
|
579 |
489 |
$0.05 |
| 3079F |
|
579 |
494 |
$0.04 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
2,363 |
1,710 |
$0.03 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,112 |
1,542 |
$0.03 |
| 3080F |
|
191 |
162 |
$0.02 |
| 3008F |
|
943 |
782 |
$0.00 |
| 1036F |
|
696 |
581 |
$0.00 |
| G9432 |
Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented |
307 |
260 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
208 |
159 |
$0.00 |
| 3075F |
|
135 |
118 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
216 |
186 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
243 |
166 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
88 |
68 |
$0.00 |
| 1034F |
|
99 |
83 |
$0.00 |
| 84132 |
|
15 |
13 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
120 |
108 |
$0.00 |
| G8851 |
Adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available, documented) |
70 |
65 |
$0.00 |
| 4004F |
|
91 |
78 |
$0.00 |
| G8842 |
Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea |
231 |
205 |
$0.00 |
| G8854 |
Documentation of reason(s) for not objectively reporting adherence to evidence-based therapy (e.g., patients who have been diagnosed with a terminal or advanced disease with an expected life span of less than 6 months, patients who decline therapy, patients who do not return for follow-up at least annually, patients unable to access/afford therapy, patient's insurance will not cover therapy) |
19 |
19 |
$0.00 |
| 84295 |
|
15 |
13 |
$0.00 |
| 82947 |
|
15 |
13 |
$0.00 |